Intramuscular Selenium Administration in Selenium‐Deficient Cattle

John Maas, John R. Peauroi, Terry Tonjes, Julianne Karlonas, Francis D. Galey, Bin Han

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Nine recently weaned Hereford heifers were randomly assigned to a control group (n = 3) or a treatment group (n = 6). The animals were selenium (Se) deficient (mean ± SD blood Se concentration = 0.024 ± 0.012 μg/mL). They were maintained on a selenium‐deficient diet, and on day 0 of the study the treatment group was given 0.05 mg Se/kg body weight intramuscularly, while the control group received a placebo. The Se concentration of blood, serum, and urine as well as the glutathione peroxidase (GSH‐Px) activity of blood and serum was measured over an 84‐day period. Peak blood Se and serum Se concentrations (mean ± SD) in the treatment group occurred at 5 hours postinjection and were 0.131 ± 0.028 μg/mL and 0.154 ± 0.027 μg/mL, respectively. The mean blood Se concentration of the treatment group was greater (P < .05) than that of the control group for the first 28 days after injection. The mean serum Se concentration of the treatment group was greater (P < .05) than that of the control group for all times after injection, except for day 56. The mean (±SD) blood GSH‐Px activity of the treatment group (12.0 ± 2.3 mU/min/mg hemoglobin) was increased (P < .05) over the control group (2.0 ± 1.4 mU/min/ mg hemoglobin) by day 28 and continued to be greater (P < .05) throughout the 84 day postinjection period. The blood GSH‐Px activity and the blood Se concentrations in the treatment group heifers did not reach concentrations considered indicative of Se adequacy (30 mU/min/mg hemoglobin and 0.10 μg/mL, respectively) except briefly, at 5 hours postinjection when the blood Se concentration of the treatment group was 0.131 ± 0.028 μg/mL. The mean serum GSH‐Px activity of the treatment group did not differ at any time from that of the control group (P≥ .17). The mean (±SD) fractional excretion (FE) of Se, as an estimate of Se excretion, was greater (P < .05) in the treatment group heifers (n = 5; 6.2 ± 2.5%) than in the control heifers (n = 3; 1.3 ± 0.6%) at 24 hours postinjection. The mean (±SD) weight gain, from day 0 to day 84, for the treatment group heifers was 63.0 ± 18.1 kg and the mean weight gain for the control group heifers was 53.1 ± 7.3 kg at 84 days postinjection and there was no difference between the groups (P < .39). Conclusions drawn from this study include: 1) the increase in blood GSH‐Px activity occurs approximately 28 days after Se injection given to Se‐deficient heifers, 2) a single label dose of injectable Se does not result in blood Se concentrations or blood GSH‐Px activity normally considered to be adequate, 3) the label dose of injectable Se, although therapeutically beneficial for nutritional myodegeneration (NMD), does not seem to be a desired method for long‐term Se supplementation of cattle consuming a Se‐deficient diet, and 4) blood Se is a better predictor of Se status than serum Se. (Journal of Veterinary Internal Medicine 1993; 7:342–348.

Original languageEnglish (US)
Pages (from-to)342-348
Number of pages7
JournalJournal of Veterinary Internal Medicine
Volume7
Issue number6
DOIs
StatePublished - Jan 1 1993

Fingerprint

Selenium
selenium
cattle
blood
blood serum
heifers
Control Groups
Injections
Serum
Therapeutics
hemoglobin
Hemoglobins
injection
Weight Gain
excretion
weight gain
white muscle disease
Diet
Veterinary Medicine
Hereford

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Intramuscular Selenium Administration in Selenium‐Deficient Cattle. / Maas, John; Peauroi, John R.; Tonjes, Terry; Karlonas, Julianne; Galey, Francis D.; Han, Bin.

In: Journal of Veterinary Internal Medicine, Vol. 7, No. 6, 01.01.1993, p. 342-348.

Research output: Contribution to journalArticle

Maas, John ; Peauroi, John R. ; Tonjes, Terry ; Karlonas, Julianne ; Galey, Francis D. ; Han, Bin. / Intramuscular Selenium Administration in Selenium‐Deficient Cattle. In: Journal of Veterinary Internal Medicine. 1993 ; Vol. 7, No. 6. pp. 342-348.
@article{3de91225454c4e26aad691c9769af034,
title = "Intramuscular Selenium Administration in Selenium‐Deficient Cattle",
abstract = "Nine recently weaned Hereford heifers were randomly assigned to a control group (n = 3) or a treatment group (n = 6). The animals were selenium (Se) deficient (mean ± SD blood Se concentration = 0.024 ± 0.012 μg/mL). They were maintained on a selenium‐deficient diet, and on day 0 of the study the treatment group was given 0.05 mg Se/kg body weight intramuscularly, while the control group received a placebo. The Se concentration of blood, serum, and urine as well as the glutathione peroxidase (GSH‐Px) activity of blood and serum was measured over an 84‐day period. Peak blood Se and serum Se concentrations (mean ± SD) in the treatment group occurred at 5 hours postinjection and were 0.131 ± 0.028 μg/mL and 0.154 ± 0.027 μg/mL, respectively. The mean blood Se concentration of the treatment group was greater (P < .05) than that of the control group for the first 28 days after injection. The mean serum Se concentration of the treatment group was greater (P < .05) than that of the control group for all times after injection, except for day 56. The mean (±SD) blood GSH‐Px activity of the treatment group (12.0 ± 2.3 mU/min/mg hemoglobin) was increased (P < .05) over the control group (2.0 ± 1.4 mU/min/ mg hemoglobin) by day 28 and continued to be greater (P < .05) throughout the 84 day postinjection period. The blood GSH‐Px activity and the blood Se concentrations in the treatment group heifers did not reach concentrations considered indicative of Se adequacy (30 mU/min/mg hemoglobin and 0.10 μg/mL, respectively) except briefly, at 5 hours postinjection when the blood Se concentration of the treatment group was 0.131 ± 0.028 μg/mL. The mean serum GSH‐Px activity of the treatment group did not differ at any time from that of the control group (P≥ .17). The mean (±SD) fractional excretion (FE) of Se, as an estimate of Se excretion, was greater (P < .05) in the treatment group heifers (n = 5; 6.2 ± 2.5{\%}) than in the control heifers (n = 3; 1.3 ± 0.6{\%}) at 24 hours postinjection. The mean (±SD) weight gain, from day 0 to day 84, for the treatment group heifers was 63.0 ± 18.1 kg and the mean weight gain for the control group heifers was 53.1 ± 7.3 kg at 84 days postinjection and there was no difference between the groups (P < .39). Conclusions drawn from this study include: 1) the increase in blood GSH‐Px activity occurs approximately 28 days after Se injection given to Se‐deficient heifers, 2) a single label dose of injectable Se does not result in blood Se concentrations or blood GSH‐Px activity normally considered to be adequate, 3) the label dose of injectable Se, although therapeutically beneficial for nutritional myodegeneration (NMD), does not seem to be a desired method for long‐term Se supplementation of cattle consuming a Se‐deficient diet, and 4) blood Se is a better predictor of Se status than serum Se. (Journal of Veterinary Internal Medicine 1993; 7:342–348.",
author = "John Maas and Peauroi, {John R.} and Terry Tonjes and Julianne Karlonas and Galey, {Francis D.} and Bin Han",
year = "1993",
month = "1",
day = "1",
doi = "10.1111/j.1939-1676.1993.tb01029.x",
language = "English (US)",
volume = "7",
pages = "342--348",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Intramuscular Selenium Administration in Selenium‐Deficient Cattle

AU - Maas, John

AU - Peauroi, John R.

AU - Tonjes, Terry

AU - Karlonas, Julianne

AU - Galey, Francis D.

AU - Han, Bin

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Nine recently weaned Hereford heifers were randomly assigned to a control group (n = 3) or a treatment group (n = 6). The animals were selenium (Se) deficient (mean ± SD blood Se concentration = 0.024 ± 0.012 μg/mL). They were maintained on a selenium‐deficient diet, and on day 0 of the study the treatment group was given 0.05 mg Se/kg body weight intramuscularly, while the control group received a placebo. The Se concentration of blood, serum, and urine as well as the glutathione peroxidase (GSH‐Px) activity of blood and serum was measured over an 84‐day period. Peak blood Se and serum Se concentrations (mean ± SD) in the treatment group occurred at 5 hours postinjection and were 0.131 ± 0.028 μg/mL and 0.154 ± 0.027 μg/mL, respectively. The mean blood Se concentration of the treatment group was greater (P < .05) than that of the control group for the first 28 days after injection. The mean serum Se concentration of the treatment group was greater (P < .05) than that of the control group for all times after injection, except for day 56. The mean (±SD) blood GSH‐Px activity of the treatment group (12.0 ± 2.3 mU/min/mg hemoglobin) was increased (P < .05) over the control group (2.0 ± 1.4 mU/min/ mg hemoglobin) by day 28 and continued to be greater (P < .05) throughout the 84 day postinjection period. The blood GSH‐Px activity and the blood Se concentrations in the treatment group heifers did not reach concentrations considered indicative of Se adequacy (30 mU/min/mg hemoglobin and 0.10 μg/mL, respectively) except briefly, at 5 hours postinjection when the blood Se concentration of the treatment group was 0.131 ± 0.028 μg/mL. The mean serum GSH‐Px activity of the treatment group did not differ at any time from that of the control group (P≥ .17). The mean (±SD) fractional excretion (FE) of Se, as an estimate of Se excretion, was greater (P < .05) in the treatment group heifers (n = 5; 6.2 ± 2.5%) than in the control heifers (n = 3; 1.3 ± 0.6%) at 24 hours postinjection. The mean (±SD) weight gain, from day 0 to day 84, for the treatment group heifers was 63.0 ± 18.1 kg and the mean weight gain for the control group heifers was 53.1 ± 7.3 kg at 84 days postinjection and there was no difference between the groups (P < .39). Conclusions drawn from this study include: 1) the increase in blood GSH‐Px activity occurs approximately 28 days after Se injection given to Se‐deficient heifers, 2) a single label dose of injectable Se does not result in blood Se concentrations or blood GSH‐Px activity normally considered to be adequate, 3) the label dose of injectable Se, although therapeutically beneficial for nutritional myodegeneration (NMD), does not seem to be a desired method for long‐term Se supplementation of cattle consuming a Se‐deficient diet, and 4) blood Se is a better predictor of Se status than serum Se. (Journal of Veterinary Internal Medicine 1993; 7:342–348.

AB - Nine recently weaned Hereford heifers were randomly assigned to a control group (n = 3) or a treatment group (n = 6). The animals were selenium (Se) deficient (mean ± SD blood Se concentration = 0.024 ± 0.012 μg/mL). They were maintained on a selenium‐deficient diet, and on day 0 of the study the treatment group was given 0.05 mg Se/kg body weight intramuscularly, while the control group received a placebo. The Se concentration of blood, serum, and urine as well as the glutathione peroxidase (GSH‐Px) activity of blood and serum was measured over an 84‐day period. Peak blood Se and serum Se concentrations (mean ± SD) in the treatment group occurred at 5 hours postinjection and were 0.131 ± 0.028 μg/mL and 0.154 ± 0.027 μg/mL, respectively. The mean blood Se concentration of the treatment group was greater (P < .05) than that of the control group for the first 28 days after injection. The mean serum Se concentration of the treatment group was greater (P < .05) than that of the control group for all times after injection, except for day 56. The mean (±SD) blood GSH‐Px activity of the treatment group (12.0 ± 2.3 mU/min/mg hemoglobin) was increased (P < .05) over the control group (2.0 ± 1.4 mU/min/ mg hemoglobin) by day 28 and continued to be greater (P < .05) throughout the 84 day postinjection period. The blood GSH‐Px activity and the blood Se concentrations in the treatment group heifers did not reach concentrations considered indicative of Se adequacy (30 mU/min/mg hemoglobin and 0.10 μg/mL, respectively) except briefly, at 5 hours postinjection when the blood Se concentration of the treatment group was 0.131 ± 0.028 μg/mL. The mean serum GSH‐Px activity of the treatment group did not differ at any time from that of the control group (P≥ .17). The mean (±SD) fractional excretion (FE) of Se, as an estimate of Se excretion, was greater (P < .05) in the treatment group heifers (n = 5; 6.2 ± 2.5%) than in the control heifers (n = 3; 1.3 ± 0.6%) at 24 hours postinjection. The mean (±SD) weight gain, from day 0 to day 84, for the treatment group heifers was 63.0 ± 18.1 kg and the mean weight gain for the control group heifers was 53.1 ± 7.3 kg at 84 days postinjection and there was no difference between the groups (P < .39). Conclusions drawn from this study include: 1) the increase in blood GSH‐Px activity occurs approximately 28 days after Se injection given to Se‐deficient heifers, 2) a single label dose of injectable Se does not result in blood Se concentrations or blood GSH‐Px activity normally considered to be adequate, 3) the label dose of injectable Se, although therapeutically beneficial for nutritional myodegeneration (NMD), does not seem to be a desired method for long‐term Se supplementation of cattle consuming a Se‐deficient diet, and 4) blood Se is a better predictor of Se status than serum Se. (Journal of Veterinary Internal Medicine 1993; 7:342–348.

UR - http://www.scopus.com/inward/record.url?scp=0027689846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027689846&partnerID=8YFLogxK

U2 - 10.1111/j.1939-1676.1993.tb01029.x

DO - 10.1111/j.1939-1676.1993.tb01029.x

M3 - Article

C2 - 8114030

AN - SCOPUS:0027689846

VL - 7

SP - 342

EP - 348

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 6

ER -